Analysis of Iliac Crest Biopsies From Patients Receiving Risedronate

Completed

Conditions studied: Osteoporosis

In brief

This study analysed and reported on the study data from three similar, risedronate studies, 1996052, 2003073, and 2003096. The objective of the study was to determine the differences in the iliac crest bone histomorphometry and bone quality in postmenopausal women who had received long term therapy with risedronate.

Key facts

Study ID

NCT00837746

Run by

Warner Chilcott

People needed

29

Starts

2003-04-01

Expected to finish

2006-10-01

Last updated by the study team

2013-06-05

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Completed month 36 of Study RVN-008993.
• Underwent an iliac crest bone biopsy at month 36.

You may not qualify if…

• Was less than 60% compliant with regard to taking study drug from the start of the study drug to month 24 of study RVN-008993.

Where it is running

• Maria Greenwald, MD — Palm Desert, California, United States
• Paul Miller, MD — Lakewood, Colorado, United States
• Grattan Woodson, MD — Decatur, Georgia, United States
• Christopher Recknor, MD — Gainesville, Georgia, United States
• Robert Recker, MD — Omaha, Nebraska, United States
• Nelson Watts, MD — Cincinnati, Ohio, United States
• Ronald D Emkey, MD — Wyomissing, Pennsylvania, United States
• Louis-Georges Ste-Marie, MD — Montreal, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.